IHT Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
IHT Wealth Management's BIIB Position: Q1 2026 in Review
IHT Wealth Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 2,473 shares — an estimated $435K sold.
IHT Wealth Management first reported a position in BIIB in Q4 2016 and held it in 19 quarters. The position peaked at $601K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- IHT Wealth Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
- IHT Wealth Management sold 2,473 Biogen shares in Q1 2026, an estimated $435K.
- IHT Wealth Management first reported a position in Biogen in Q4 2016 and held it in 19 quarters.
- IHT Wealth Management's Biogen position peaked at $601K in Q2 2021.
- 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on IHT Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.